Quarterly report · Q2
3034.TEDINET S100SA13
Period2023-04-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥88.5bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥170.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥82.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥3.6bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥4.0bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥3.7bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥10.1bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.2bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥3.6bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥4.2bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.9bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.7bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.4bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.9bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥2.4bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥107.4bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥101.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥91.0bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥57.1bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥53.0bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥50.3bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥48.9bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥45.9bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥17.4bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥18.8bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥17.3bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.6bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.3bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥16.5bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥6.4bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥11.7bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥4.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥9.9bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥7.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥2.2bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥5.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥50.8 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.58 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥152.96 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥64.11 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥36.92 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 46.8% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.9% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.4% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥231m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥231m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥1.8bn |
| jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥81.0bn |
| jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥81.0bn |
| jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥63m |
| jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥4.7bn |
| jpcrp040300-q2r_E03476-000Medical Relatedreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥7.7bn |
| jpcrp040300-q2r_E03476-000Medical Relatedreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥7.6bn |
| jpcrp040300-q2r_E03476-000Medical Relatedreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥167m |
| jpcrp040300-q2r_E03476-000Medical Relatedreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥658m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥88.8bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥88.5bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥231m |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥5.4bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥181m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥181m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥1.7bn |
| jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥75.6bn |
| jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥75.6bn |
| jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥58m |
| jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥5.1bn |
| jpcrp040300-q2r_E03476-000Medical Relatedreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥7.0bn |
| jpcrp040300-q2r_E03476-000Medical Relatedreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥6.9bn |
| jpcrp040300-q2r_E03476-000Medical Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥123m |
| jpcrp040300-q2r_E03476-000Medical Relatedreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥645m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥82.6bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥82.5bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥181m |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥5.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 510
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)田 中 淳 一 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)渡 邊 崇 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 82459000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 88540000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 170036000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 4174000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 3675000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 10098000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 2366000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 1888000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 5656000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 2367000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 1894000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 5657000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 45918000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 50260000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 48856000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 91027000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 107365000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 101905000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 64.11 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 50.80 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 152.96 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.504 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.468 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.479 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 4711000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 6391000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 11662000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -1681000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -9905000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -7013000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -5223000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | 2170000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -2569000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 14323000000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 17253000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 18596000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 36.92 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 23.58 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 38902785 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 38902785 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 38902785 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 38902785 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |